Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Allergen Immunotherapy Extract (Mansoura University Hospital) refers to the specific allergen preparations used in clinical research at Mansoura University Hospital for the treatment of allergic bronchial asthma. This therapy involves the repeated administration of specific allergens (such as house dust mites or pollens) to patients with IgE-mediated allergic conditions. The goal is to induce immunological tolerance, thereby reducing allergic symptoms and inflammatory reactions upon natural exposure to the allergens. The treatment can be administered via sublingual (SLIT) or subcutaneous (SCIT) routes. It works by modulating the immune system's response, typically leading to a decrease in allergen-specific IgE levels and a reduction in eosinophilic airway inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on allergen immunotherapy extract-Mansoura University Hospital-allergic asthma.